Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Smilow Cancer Center/yale-New Haven Hospital
New Haven, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Smilow Cancer Hospital Care Center-Trumbull
Trumbull, Connecticut, United States
- Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- Weisberg Cancer Treatment Center
Farmington Hills, Michigan, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Ut Md Anderson Cancer Center
Houston, Texas, United States
- Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
- University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jan 2020
- Primary completion
- 12 Mar 2025
- Completion
- 10 Jul 2026
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 24
- Registry id
- NCT03878095
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.